Kaposi ’ s Sarcoma-Associated Herpesvirus ORF 54 / dUTPase downregulates a ligand for the NK 1 activating receptor NKp 44 2

Kaposi’s Sarcoma-Associated Herpesvirus ORF54/dUTPase downregulates a ligand for the NK 1 activating receptor NKp44 2 Alexis Madrid and Don Ganem# 3 4 1 Howard Hughes Medical Institute and GW Hooper Foundation Laboratories 5 University of California, San Francisco CA 94143 6 7 2 Novartis Institutes for Biomedical Research 8 Emeryville, CA 94608 9 10 #Corresponding Author 11 Novartis Institutes for Biomedical Research 12 Emeryville, CA 94608 13 Phone: 510-923-3400 14 Fax: 510-923-3747 15 Email: don.ganem@novartis.com 16 17 18 Condensed title: KSHV downregulation of NKp44L 19 20 21 22 Copyright © 2012, American Society for Microbiology. All Rights Reserved. J. Virol. doi:10.1128/JVI.00252-12 JVI Accepts, published online ahead of print on 6 June 2012

[1]  R. Sun,et al.  The Anti-interferon Activity of Conserved Viral dUTPase ORF54 is Essential for an Effective MHV-68 Infection , 2011, PLoS pathogens.

[2]  D. Ganem,et al.  Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. , 2011, Journal of virological methods.

[3]  E. Campbell,et al.  Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. , 2010, Cell host & microbe.

[4]  H. Agut,et al.  HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells , 2009, AIDS.

[5]  A. Carbone.  Kshv/hhv8-associated lymphomas , 2009 .

[6]  G. Carpenter,et al.  Trafficking of receptor tyrosine kinases to the nucleus. , 2009, Experimental cell research.

[7]  Noam Stern-Ginossar,et al.  Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. , 2009, Cell host & microbe.

[8]  D. Ganem,et al.  A Kaposi's Sarcoma-Associated Herpesvirus Protein That Forms Inhibitory Complexes with Type I Interferon Receptor Subunits, Jak and STAT Proteins, and Blocks Interferon-Mediated Signal Transduction , 2009, Journal of Virology.

[9]  Mair E. M. Thomas,et al.  Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity , 2008, Proceedings of the National Academy of Sciences.

[10]  M. Jarahian,et al.  Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44 , 2007, PloS one.

[11]  G. Carpenter,et al.  Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. , 2007, Molecular biology of the cell.

[12]  H. Šimić,et al.  The herpesviral Fc eceptor fcr-1 as a potent Down-regulator of the NKG2D ligand MULT-1 and H60 , 2006 .

[13]  D. Cosman,et al.  Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. , 2006, Biochemical and biophysical research communications.

[14]  Roberta Castriconi,et al.  Surface NK receptors and their ligands on tumor cells. , 2006, Seminars in immunology.

[15]  D. Ganem,et al.  KSHV infection and the pathogenesis of Kaposi's sarcoma. , 2006, Annual review of pathology.

[16]  A. Davison,et al.  New Genes from Old: Redeployment of dUTPase by Herpesviruses , 2005, Journal of Virology.

[17]  H. Ploegh,et al.  Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond , 2005, Immunological reviews.

[18]  S. Cusack,et al.  Epstein Barr Virus dUTPase , 2005 .

[19]  D. Ganem,et al.  RNAs in the Virion of Kaposi's Sarcoma-Associated Herpesvirus , 2005, Journal of Virology.

[20]  P. Tomasec,et al.  Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141 , 2005, Nature Immunology.

[21]  M. Wilmanns,et al.  Structural Insights into the Catalytic Mechanism of Phosphate Ester Hydrolysis by dUTPase*♦ , 2004, Journal of Biological Chemistry.

[22]  J. Vieira,et al.  Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. , 2004, Virology.

[23]  P. Caposio,et al.  Evidence that the human cytomegalovirus 46-kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts. , 2004, Virology.

[24]  B. Chandran,et al.  Concurrent Expression of Latent and a Limited Number of Lytic Genes with Immune Modulation and Antiapoptotic Function by Kaposi's Sarcoma-Associated Herpesvirus Early during Infection of Primary Endothelial and Fibroblast Cells and Subsequent Decline of Lytic Gene Expression , 2004, Journal of Virology.

[25]  D. Ganem,et al.  Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.

[26]  L. Moretta,et al.  Unravelling natural killer cell function: triggering and inhibitory human NK receptors , 2004, The EMBO journal.

[27]  D. Ganem,et al.  Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.

[28]  L. Lanier,et al.  NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.

[29]  D. Ganem,et al.  A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition , 2001, The Journal of cell biology.

[30]  K. Makino,et al.  Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.

[31]  W. Fanslow,et al.  ULBP1, 2, 3: novel MHC class I‐related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells , 2001, European journal of immunology.

[32]  R. Armitage,et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.

[33]  R. Johnson,et al.  Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. , 2000, Immunity.

[34]  D. Ganem,et al.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Jae U. Jung,et al.  Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.

[36]  E. Kremmer,et al.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) ORF54 encodes a functional dUTPase expressed in the lytic replication cycle. , 1999, The Journal of general virology.

[37]  G. Muscat,et al.  Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target. , 1999, Journal of molecular biology.

[38]  R. Biassoni,et al.  NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily , 1999, The Journal of experimental medicine.

[39]  D. Ganem,et al.  Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. , 1998, Virology.

[40]  P. Nyman,et al.  Kinetic properties and stereospecificity of the monomeric dUTPase from herpes simplex virus type 1 , 1998, FEBS letters.

[41]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Ambroziak,et al.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.

[43]  I. Lehman,et al.  dUTPase from herpes simplex virus type 1; purification from infected green monkey kidney (Vero) cells and from an overproducing Escherichia coli strain. , 1993, Protein expression and purification.

[44]  J. Orange,et al.  Natural killer cells in human health and disease. , 2006, Clinical immunology.

[45]  L. Lanier,et al.  Viral modulation of NK cell immunity , 2005, Nature Reviews Microbiology.

[46]  L. Lanier,et al.  The Cytomegalovirus m 155 Gene Product Subverts Natural Killer Cell Antiviral Protection by Disruption of H 60 – NKG 2 D Interactions , 2004 .